Lower limits of detection, biological detection limits, functional sensitivity, or residual cancer detection limit? Sensitivity reports on prostate-specific antigen assays mislead clinicians.
Stamey
T A
TA
Department of Urology S-287, Stanford University School of Medicine, Stanford, CA 94305, USA.
D006801:Humans; D007118:Immunoassay; D008297:Male; D008832:Microchemistry; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000601:surgery; D012680:Sensitivity and Specificity; D017211:Treatment Failure
D017430:Prostate-Specific Antigen